Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Tax Provisions (2017 - 2025)

Organogenesis Holdings has reported Tax Provisions over the past 9 years, most recently at $10.2 million for Q4 2025.

  • Quarterly results put Tax Provisions at $10.2 million for Q4 2025, up 296.4% from a year ago — trailing twelve months through Dec 2025 was $438000.0 (up 111.94% YoY), and the annual figure for FY2025 was $438000.0, up 111.94%.
  • Tax Provisions for Q4 2025 was $10.2 million at Organogenesis Holdings, up from -$407000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for ORGO hit a ceiling of $10.2 million in Q4 2025 and a floor of -$32.1 million in Q4 2021.
  • Median Tax Provisions over the past 5 years was $122500.0 (2021), compared with a mean of -$1.3 million.
  • Peak annual rise in Tax Provisions hit 1703.7% in 2021, while the deepest fall reached 8207.58% in 2021.
  • Organogenesis Holdings' Tax Provisions stood at -$32.1 million in 2021, then skyrocketed by 97.78% to -$712000.0 in 2022, then tumbled by 72.47% to -$1.2 million in 2023, then skyrocketed by 310.1% to $2.6 million in 2024, then surged by 296.4% to $10.2 million in 2025.
  • The last three reported values for Tax Provisions were $10.2 million (Q4 2025), -$407000.0 (Q3 2025), and -$2.4 million (Q2 2025) per Business Quant data.